Abstract
Background: The novel coronavirus (SARS-CoV-2) disease spread all over the world and lead to global pandemic, has different outcomes on patients depends on many factors, such as comorbidity, obesity, age and associated with significant morbidity and mortality.
Objective: the study amid to determine the effect of abnormal BMI in patients with coronavirus disease (COVID-19) on their disease outcomes.
Methods: the study involved analyzing the data of 210 post COVID-19 patients, which was collected through answering specific questions related to the relation of dieses outcomes and patients BMI.
Results: the mean age of patients was 34.7, 77 were female and 133 were males, 11% did suffer from shortness of breath of those who suffered from shortness of breath 70% were overweight and above normal BMI. 60% of moderately obese and 85% of severely obese people show symptoms for more than a week.
Conclusions: There is a correlation between BMI and COVID-19 outcomes, represented through moderate and severe obese patients were suffered from COVID-19 symptoms for longer duration than others.

Key words: COVID-19, SARS-COV-2, body mass index, World Health Organization

Similar Articles

Integrated molecular and affiliation network analysis: Core-periphery social clustering is associated with HIV transmission patterns.
Fujimoto K, Paraskevis D, Kuo JC, Hallmark CJ, Zhao J, Hochi A, Kuhns LM, Hwang LY, Hatzakis A, Schneider JA
Social networks. 2022; 68(): 107-117

SARS-CoV-2 infection in patients with thyroid disease: a cross-sectional study.
Nguyen C, Yale K, Ghigi A, Zheng K, Mesinkovska NA, Wambier CG, Cadegiani FA, Goren A
Annals of thyroid. 2022; 6():

The process of National Health Insurance coverage for Chuna Manual Therapy in Korea: A qualitative study.
Yu J, Shin BC, Kim H, Hyun E, Lee JH, Kim MR, Lim B
Integrative medicine research. 2022; 11(1): 100746

Neurorehabilitation using a voluntary driven exoskeletal robot improves trunk function in patients with chronic spinal cord injury: a single-arm study.
Okawara H, Tashiro S, Sawada T, Sugai K, Matsubayashi K, Kawakami M, Nori S, Tsuji O, Nagoshi N, Matsumoto M, Nakamura M
Neural regeneration research. 2022; 17(2): 427-432

Dysbalance of ACE2 levels - a possible cause for severe COVID-19 outcome in COPD.
Fließer E, Birnhuber A, Marsh LM, Gschwandtner E, Klepetko W, Olschewski H, Kwapiszewska G
The journal of pathology. Clinical research. 2021; ():